# Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

> **NCT03430154** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 317 (actual)

## Conditions studied

- Haemophilia A, Haemophilia B, Obesity

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT03430154
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2018-04-29
- **Final completion:** 2018-04-29
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2018-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430154, "Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03430154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*